BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31650353)

  • 1. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
    Kóthy P; Holló G
    Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
    Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
    Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
    Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):290-7. PubMed ID: 23425430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
    Topouzis F; Goldberg I; Bell K; Tatham AJ; Ridolfi A; Hubatsch D; Nicolela M; Denis P; Lerner SF
    Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
    Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
    Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    Jin SW; Lee SM
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
    Weinreb RN; Bacharach J; Fechtner RD; Kahook MY; Wirta D; Burmaster S; Meng X; Hubatsch DA
    Ophthalmology; 2019 Aug; 126(8):1095-1104. PubMed ID: 30403988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
    Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
    Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
    Alezzandrini A; Hubatsch D; Alfaro R
    Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.
    Greig SL; Deeks ED
    Drugs Aging; 2015 Mar; 32(3):251-60. PubMed ID: 25732405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.
    Tekeli O; Köse HC
    Turk J Ophthalmol; 2022 Aug; 52(4):262-269. PubMed ID: 36017234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.
    Feldman RM; Katz G; McMenemy M; Hubatsch DA; Realini T
    Am J Ophthalmol; 2016 May; 165():188-97. PubMed ID: 26940161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies.
    Realini T; Nguyen QH; Katz G; DuBiner H
    Eye (Lond); 2013 Jul; 27(7):841-7. PubMed ID: 23640612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients.
    Sakata R; Mizoue S; Yoshikawa K; Adachi M; Ohkubo S; Hamada N; Naito T; Muramatsu T; Hara T; Asato R; Aihara M
    Jpn J Ophthalmol; 2023 Nov; 67(6):668-677. PubMed ID: 37596444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series.
    Joh HJ; Jin SW
    Jpn J Ophthalmol; 2019 Jul; 63(4):322-327. PubMed ID: 31115761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.